Slate Medicines
Business Services · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Raleigh, North Carolina, United StatesWebsite
www.slatemedicines.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Slate Medicines
Slate Medicines is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders. The Companys lead program, SLTE-1009, is a potential best-in-class subcutaneous anti-PACAP for the prevention of migraine and other headache disorders. The company is backed by leading healthcare investors including RA Capital Management, Forbion, Foresite Capital, and an additional undisclosed biotech investor.Explore more
Slate Medicines Org Chart
JU
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Slate Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Slate Medicines recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Slate Medicines
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Slate Medicines has recently received funding, and reach out quickly before it becomes old news!
Click to see if Slate Medicines had a recent Job posting/layoffs
Slate Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Slate Medicines has new funding data
Product Launch: Get notified when Slate Medicines launches new products
Check out if Slate Medicines is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Slate Medicines as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Slate Medicines is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Slate Medicines is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Slate Medicines.
Slate Medicines financials insights
Gather financial insights about Slate Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series A
$130M
Most Recent Scoops
New Hire
Executive Move
Gregory Oakes has recently joined the organization as Chief Executive Officer.
Executive Moves, New Hire
Funding
Funding
New Hire
Executive Move
Neil Buckley has recently joined the organization as Chief Operating Officer & President.
Executive Moves, New Hire
New Hire
Executive Move
Slate Medicines News & Media
Slate Medicines Appoints Mark W. Hahn to Board of Directors
By Daniella Parra Slate Medicines, a private biotech company developing new treatments for migraine and other headache disorders, has appointed Mark W. Hahn to its Board of Directors, they said. The company said Hahn brings more than 25 years of life sciences leadership experience, including serving as CFO of Verona Pharma, where he helped guide […] The post Slate Medicines Appoints Mark W. Hahn to Board of Directors appeared first on ExecEdge.Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
RALEIGH, N.C., July 15, 2026 (GLOBE NEWSWIRE) -- Slate Medicines (Slate), a privately-held biotech company advancing next-generation therapeutics for migraine and other headache disorders, today announced the appointment of Mark W. Hahn to the company's Board of Directors. Mr. Hahn brings more than 25 years of leadership experience building and scaling life sciences companies.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Slate Medicines
Sign Up For FreeTo access detailed company insights
Slate Medicines is a biotech company focused on advancing next generation therapeutics for migraine and other headache disorders. The Companys lead program, SLTE-1009, is a potential best-in-class subcutaneous anti-PACAP for the prevention of migraine and other headache disorders. The company is backed by leading healthcare investors including RA C... Read More
